Consolidated Statutes and Regulations
Consolidated Statutes
Consolidated Regulations
Annual Statutes and Regulations
Annual Statutes
Annual Regulations
Additional information
Québec Official Publisher
What’s new?
Information note
Policy of the Minister of Justice
Laws: Amendments
Laws: Provisions not in force
Laws: Provisions brought into force
Annual Statutes: PDF versions since 1996
Regulations: Amendments
Annual Regulations: PDF versions since 1996
Court Decisions
P-12, r. 6 - Regulation respecting the medications that a podiatrist who obtained a permit to practise before 1976 may administer or prescribe
Schedule
Disposition versions
SCHEDULE II
NOTE: Medications without specification are intended for topical application.
________________________________________________________________
Substances Specification
________________________________________________________________
Acetaminophen Pharmaceutical form intended
for oral and rectal administration
Acetaminophen and Pharmaceutical form intended
codeine for oral administration
(in combination) containing 30 mg or less of
codeine per tablet
Acetic, Quantity limited to 24 tablets/
glacial acid 72 hours
Acetylsalicyclic Pharmaceutical form intended
acid for oral administration
Aluminium and its salts
Almond, sweet oil
Amcinonide Quantity limited for 30 days
Anthralin (dithranol)
Silver nitrate
Silver sulfadiazine
Colloidal oatmeal
Bacitracin and its salts
Beclomethasone and its salts
Benzalkonium
Benzocaine
Betamethasone Pharmaceutical forms
acetate and intended for administration by
phosphate intramuscular or intradermal
injection
Betamethasone benzoate
Betamethasone Quantity limited for 30 days
dipropionate
Betamethasone valerate
Bleomycin sulfate Pharmaceutical form injectable in
the plantar lesion without
exceeding 0.8 units up to a maximum
of 5 units per treatment
Bupivacaine and Pharmaceutical form intended for
its salts administration by injection for
local use only
Calcipotriol
Camphor
Cantharidin
Capsaicin
Celecoxib Pharmaceutical form intended for
oral administration
Quantity limited for 30 days
Cetirizine Pharmaceutical form intended for
hydrochloride oral administration
Chlorhexidine and its salts
Chlorprocaine Pharmaceutical form intended for
hydrochloride administration by injection for
local use only
Ciclopirox olamine
Cinchocaine
Clioquinor
(iodochlorhydroxyquin)
Clobetasol Quantity limited for 30 days
proprionate
Clobetasone butyrate
Clotrimazole
Dakin’s solution
Desonide
Desoximetasone Quantity limited for 30 days
Dichloracetic acid
Diclofenac, Pharmaceutical form intended
potassic and sodic for oral administration
Quantity limited for 30 days
Diflucortolone Quantity limited for 30 days
valerate
Dyphenhydramine Pharmaceutical forms intended
for oral administration and
administration by intramuscular,
subcutaneous or intradermal
injection
Epinephrine Pharmaceutical forms for the
(adrenaline) emergency treatment of
anaphylactic reactions in the
form of auto-injector or vial
Pharmaceutical form associated
with local anaesthetics
Erythromycin
Ethyl chloride
Fluocinolone Quantity limited for 30 days
acetonide
Fluocinode Quantity limited for 30 days
5-fluorouracil 5% pharmaceutical form intended
for topical application in the
case of plantar warts resistant to
first-line treatments
Formaline
Framycetin sulfate
Fusidic acid
Gentamicin sulfate
Gentian, violet
Mineral and vegetal tar
Gramicidin
Hexachlorophene
Mineral oil
Hydrocortisone and its salts
Hydroxyzine Pharmaceutical form intended for
hydrochloride oral administration
Ibuprofen Pharmaceutical form intended for
oral administration
Quantity limited for 30 days
Povidone iodine
Ketoconazole
Lactic acid
Lanolin
Lidocaine and Pharmaceutical forms intended for
its salts topical application and
administration by injection for
local use only
Loratadine Pharmaceutical form intended for
oral administration
Lorazepam Pharmaceutical form intended for
oral and sublingual administration
in anticipation of surgical
procedures, containing 0.5 mg or
1 mg of Lorazepam per tablet
Quantity limited to 4 tablets
Menthol
Mepivacaine Pharmaceutical form intended for
administration by injection
for local use only
Methylpolysiloxanes
Methylprednisolone Pharmaceutical forms intended for
acetate topical application and
administration by injection for
local use only
Miconazole nitrate
Mometasone furorate
Mupirocin
Naproxen Pharmaceutical form intended for
oral administration
Quantity limited for 30 days
Neomycin sulfate
Nystatin
Phenol
Podophyllin
Polymyxin B sulfate
Pramoxine
Prilocaine Pharmaceutical forms intended for
topical application and
administration by injection for
local use only
Procaine Pharmaceutical form intended for
administration by injection for
local use only
Resorcinol and its salts
Methyl salicylate
Triethanolamine salicylate
Salicylic acid
Silicone
Sulphur, colloidal,
precipitate or sublimate
Tazarotene
Terbinafine
Tetracaine and Pharmaceutical forms intended for
its salts topical application and
administration by injection for
local use only
Tolnaftate
Triamcinolone Quantity limited for 30 days
acetonide
Triamcinolone Pharmaceutical forms intended for
hexacetonide administration by intramuscular or
intradermal injection
Quantity limited for 30 days
Trichloroacetic acid
Urea Pharmaceutical form intended for
topical application, with a
concentration of 30% or less
White petroleum jelly
Zinc oxide
SCHEDULE II
NOTE : Medications without specification are intended for topical application.
________________________________________________________________
Substances Specification
________________________________________________________________
Acetaminophen Pharmaceutical form intended
for oral and rectal administration
Acetaminophen and Pharmaceutical form intended
codeine for oral administration
(in combination) containing 30 mg or less of
codeine per tablet
Acetic, Quantity limited to 24 tablets/
glacial acid 72 hours
Acetylsalicyclic Pharmaceutical form intended
acid for oral administration
Aluminium and its salts
Almond, sweet oil
Amcinonide Quantity limited for 30 days
Amino acids
Anthralin (dithranol)
Silver nitrate
Silver sulfadiazine
Colloidal oatmeal
Bacitracin and its salts
Beclomethasone and its salts
Benzalkonium
Benzocaine
Betamethasone Pharmaceutical forms
acetate and intended for administration by
phosphate intramuscular or intradermal
injection
Betamethasone benzoate
Betamethasone Quantity limited for 30 days
dipropionate
Betamethasone valerate
Bleomycin sulfate Pharmaceutical form injectable in
the plantar lesion without
exceeding 0.8 units up to a maximum
of 5 units per treatment
Bupivacaine and Pharmaceutical form intended for
its salts administration by injection for
local use only
Calcipotriol
Calcium acetate
Camphor
Cantharin
Capsaicin
Celecoxib Pharmaceutical form intended for
oral administration
Quantity limited for 30 days
Cetirizine Pharmaceutical form intended for
hydrochloride oral administration
Cetrimid
Chlorhexidine and its salts
Chlorphenesin
Chlorprocaine Pharmaceutical form intended for
hydrochloride administration by injection for
local use only
Ciclopirox olamine
Cinchocaine
Clioquinor
(iodochlorhydroxyquin)
Clobetasol Quantity limited for 30 days
proprionate
Clobetasone butyrate
Clotrimazole
Collagenase
Dakin’s solution
Desonide
Desoximetasone Quantity limited for 30 days
Deoxyribonuclease
Dichloracetic acid
Diclofenac, Pharmaceutical form intended
potassic and sodic for oral administration
Quantity limited for 30 days
Diflucortolone Quantity limited for 30 days
valerate
Dyphenhydramine Pharmaceutical forms intended
for oral administration and
administration by intramuscular,
subcutaneous or intradermal
injection
Econazole nitrate
Epinephrine Pharmaceutical forms for the
(adrenaline) emergency treatment of
anaphylactic reactions in the
form of auto-injector or vial
Pharmaceutical form associated
with local anaesthetics
Erythromycin
Ethyl chloride
Fibrinolysin
Flumetasone pivalate
Fluocinolone Quantity limited for 30 days
acetonide
Fluocinode Quantity limited for 30 days
5-fluorouracil 0.1% pharmaceutical form intended
for topical application in the
case of plantar warts resistant to
first-line treatments
Formaline
Framycetin sulfate
Fusidic acid
Gentamicin sulfate
Gentian, violet
Mineral and vegetal tar
Gramicidin
Halcinodide Quantity limited for 30 days
Hexachlorophene
Mineral oil
Hydrocortisone and its salts
Hydroxyzine Pharmaceutical form intended for
hydrochloride oral administration
Ibuprofen Pharmaceutical form intended for
oral administration
Quantity limited for 30 days
Povidone iodine
Iodine tincture
Isopropyl myristate
Ketoconazole
Lactic acid
Lanolin
Lidocaine and Pharmaceutical forms intended for
its salts topical application and
administration by injection for
local use only
Loratadine Pharmaceutical form intended for
oral administration
Lorazepam Pharmaceutical form intended for
oral and sublingual administration
in anticipation of surgical
procedures, containing 0.5 mg or
1 mg of Lorazepam per tablet
Quantity limited to 4 tablets
Mafenide and its salts
Menthol
Mepivacaine Pharmaceutical form intended for
administration by injection
for local use only
Methylpolysiloxanes
Methylprednisolone Pharmaceutical forms intended for
acetate topical application and
administration by injection for
local use only
Miconazole nitrate
Mometasone furorate
Mupirocin
Naproxen Pharmaceutical form intended for
oral administration
Quantity limited for 30 days
Neomycin sulfate
Nystatin
Oxiconazole
Phenol
Podophyllin
Polymyxin B sulfate
Pramoxine
Prilocaine Pharmaceutical forms intended for
topical application and
administration by injection for
local use only
Procaine Pharmaceutical form intended for
administration by injection for
local use only
Resorcinol and its salts
Rofecoxib Pharmaceutical form intended for
oral administration
Quantity limited for 30 days
Diethylamine salicylate
Magnesium salicylate
Methyl salicylate
Triethanolamine salicylate
Salicylic acid
Synthetic sebum
Silicone
Sodium thiosulfate
Sulphur, colloidal,
precipitate or sublimate
Tazarotene
Terbinafine
Tetracaine and Pharmaceutical forms intended for
its salts topical application and
administration by injection for
local use only
Tioconazole
Tolnaftate
Triamcinolone Quantity limited for 30 days
acetonide
Triamcinolone Pharmaceutical forms intended for
hexacetonide administration by intramuscular or
intradermal injection
Quantity limited for 30 days
Trichloroacetic acid
Urea Pharmaceutical form intended for
topical application, with a
concentration of 30% or less
White petroleum jelly
Zinc oxide
